Each patient program will have a unique timeline.  For some programs, drug discovery is relatively straight forward and an optimal ASO can be identified relatively quickly. For others, the discovery process can be longer and in some cases, we may not be able to identify an optimal ASO to move forward in development.  At a minimum, our programs will be approximately 18 months, but this timeline can slip significantly if there are any problems with ASO identification and development.